Skip to main content
. Author manuscript; available in PMC: 2015 Jul 3.
Published in final edited form as: Cell Stem Cell. 2014 Jul 3;15(1):14–25. doi: 10.1016/j.stem.2014.06.009

Table 1. Summary of the regenerative capacity, mechanisms, and disease states of representative mammalian tissues.

The process of regeneration is summarized for six different tissues, each with varying regenerative capacities: skin, heart, skeletal muscle, CNS, liver and bone. For each, steps that have the potential to be influenced by immunity are listed as well as the disease state and summary of immune targeted therapeutics.

TISSUE DEBRIS
CLEARNACE
MECHANISM
PROGENITOR
CELL POOL
IMMUNE-DERIVED
STIMULI
POLARIZATION &
HETEROGENITY
DISEASE STATE
DUE TO FAILED
REGENERATION
DEFECT DRUGS
TARGETING
IMMUNITY
Skin (dermis) Macrophages, fibroblasts, keratinocytes Fibroblasts, endothelial cells TGFβ, EGF, VEGF, IGF Early and late macrophages (similar to M1/M2) Full-thickness wound scarring in adults Excessive inflammation
Decreased migration
Collagen accumulation
IFN-α, IFN-β, IFN-γ; steroids
Heart M1 or Ly-6Chi monocytes/macrophages Resident cardiomyocytes n/a Four pools of cardiac macrophages; sequential Ly6Chi, Ly6Clo Myocardial infarction Heart failure Lack of progenitors; Insufficient immune polarization ACE inhibitors
Skeletal muscle Macrophages and FAPs Satellite cells Treg amphiregulin, IL-6, IL-1β, TNFα, IGF1, TGFβ Muscle Treg; M1/M2 Muscular dystrophy Myofiber defect; satellite cell exhaustion; chronic inflammation Glucocorticoids
CNS (myelination) Macrophages and microglia Oligodendrocyte progenitor cells IGF1 M1/M2 Multiple sclerosis Impaired clearance of myelin debris anti-GM-CSF; Pioglitazone (PPARg agonist); Glatiramer acetate
Liver Kupffer cell and liver macrophages Hepatocytes and Hepatic Progenitor Cells Eosinophil IL-4; Kupffer IL-6, TNFα Inflammatory and restorative macrophages; Th1, Th2, Th17 lymphocytes Chronic liver disease (viral, toxic, autoimmune, metabolic) Unresolved fibrosis TLR4, CCR2 inhibitors; PPAR-α/β agonists
Bone Osteoclast Monocyte progenitor Csf1 n/a Osteopetrosis or osteoperosis Lack of or excessive bone resorption IFN-γ1b, corticosteroid; RANKL inhibitor (mAb)